Phase II Trial of Gleevec (Imatinib Mesylate, STI-571) in Metastatic Melanoma.
Phase of Trial: Phase II
Latest Information Update: 27 Jul 2012
At a glance
- Drugs Imatinib (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 19 Aug 2010 Actual end date (Jan 2005) added as reported by ClinicalTrials.gov.
- 19 Aug 2010 Status changed from suspended to completed as reported by ClinicalTrials.gov.
- 21 Sep 2005 New trial record.